Inhibition of iRhom1 by CD44-targeting nanocarrier for improved cancer immunochemotherapy.

Nat Commun · 2024 · PMC10766965 · PMID 38177179

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

This information may be highly significant for the future design of more effective tumor-targeting NPs.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.